Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.

Sakata VM, da Silva FT, Hirata CE, Marin ML, Rodrigues H, Kalil J, Costa RA, Yamamoto JH.

Graefes Arch Clin Exp Ophthalmol. 2015 Jan 16. [Epub ahead of print]

PMID:
25592477
2.

Sjögren's syndrome: An underdiagnosed condition in mixed connective tissue disease.

Usuba FS, Lopes JB, Fuller R, Yamamoto JH, Alves MR, Pasoto SG, Caleiro MT.

Clinics (Sao Paulo). 2014 Mar;69(3):158-62. doi: 10.6061/clinics/2014(03)02.

3.

Choroidal bulging in patients with Vogt-Koyanagi-Harada disease in the non-acute uveitic stage.

Sakata VM, da Silva FT, Hirata CE, Takahashi WY, Costa RA, Yamamoto JH.

J Ophthalmic Inflamm Infect. 2014 Feb 18;4(1):6. doi: 10.1186/1869-5760-4-6.

4.

Diagnosis and classification of Vogt-Koyanagi-Harada disease.

Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH.

Autoimmun Rev. 2014 Apr-May;13(4-5):550-5. doi: 10.1016/j.autrev.2014.01.023. Epub 2014 Jan 15. Review.

PMID:
24440284
5.

Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease.

da Silva FT, Sakata VM, Nakashima A, Hirata CE, Olivalves E, Takahashi WY, Costa RA, Yamamoto JH.

Br J Ophthalmol. 2013 Jan;97(1):70-4. doi: 10.1136/bjophthalmol-2012-302089. Epub 2012 Oct 25.

PMID:
23099292
6.

Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.

da Silva FT, Hirata CE, Sakata VM, Olivalves E, Preti R, Pimentel SL, Gomes A, Takahashi WY, Costa RA, Yamamoto JH.

BMC Ophthalmol. 2012 Aug 13;12:40. doi: 10.1186/1471-2415-12-40.

7.

Increased frequency of anti-retina antibodies in asymptomatic patients with chronic t. gondii infection.

Cursino SR, Costa TB, Yamamoto JH, Meireles LR, Silva MA, Andrade Junior HF.

Clinics (Sao Paulo). 2010;65(10):1027-32.

8.

Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.

Zaghetto JM, Yamamoto MM, Souza MB, Silva FT, Hirata CE, Olivalves E, Yamamoto JH.

Arq Bras Oftalmol. 2010 Jan-Feb;73(1):40-6.

9.

Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms.

Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU.

Ann Trop Med Parasitol. 2010 Jan;104(1):3-23. doi: 10.1179/136485910X12607012373957. Review.

PMID:
20149289
10.

Fundus-based and electroretinographic strategies for stratification of late-stage Vogt-Koyanagi-Harada disease patients.

da Silva FT, Hirata CE, Olivalves E, Oyamada MK, Yamamoto JH.

Am J Ophthalmol. 2009 Dec;148(6):939-45.e3. doi: 10.1016/j.ajo.2009.06.029. Epub 2009 Sep 24.

PMID:
19781687
11.

New insights into Vogt-Koyanagi-Harada disease.

Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH.

Arq Bras Oftalmol. 2009 May-Jun;72(3):413-20. Review.

12.

Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories.

da Silva FT, Damico FM, Marin ML, Goldberg AC, Hirata CE, Takiuti PH, Olivalves E, Yamamoto JH.

Am J Ophthalmol. 2009 Feb;147(2):339-345.e5. doi: 10.1016/j.ajo.2008.08.034. Epub 2008 Nov 7.

PMID:
18992868
13.

Optical coherence tomography of a subretinal granuloma in simultaneous visceral and ocular larva migrans.

Carvalho da Silva FT, Yamamoto JH, Hirata CE, Nakashima Y, Chieffi PP, Olivalves E.

Retin Cases Brief Rep. 2008 Fall;2(4):316-8. doi: 10.1097/ICB.0b013e318113244a.

PMID:
25390601
14.

Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.

Cuchacovich M, Merino G, Yamamoto JH, Villarroel F, Saavedra T, Jofre S, Gatica H, Velasquez V, Pizzo SV, Gonzalez-Gronow M.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S27-34.

PMID:
16273761
15.

T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.

Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH.

Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2465-71.

16.

Anti-SS-A/Ro reactivity in patients with Vogt-Koyanagi-Harada syndrome.

Shinzato M, Yamamoto JH, Hirata CE, Olivalves E, Bonfá E.

Lupus. 2004;13(4):279-80. No abstract available.

PMID:
15176666
17.

MICA polymorphism in a sample of the São Paulo population, Brazil.

Marin ML, Savioli CR, Yamamoto JH, Kalil J, Goldberg AC.

Eur J Immunogenet. 2004 Apr;31(2):63-71.

PMID:
15086345
18.

Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus.

Yamamoto JH, Boletti DI, Nakashima Y, Hirata CE, Olivalves E, Shinzato MM, Okay TS, Santo RM, Duarte MI, Kalil J.

Br J Ophthalmol. 2003 May;87(5):651-2. No abstract available.

19.

Synthesis and characterization of mixed ruthenium/platinum mu(4)-phosphinidene, phosphorus monoxide, and related clusters.

Scoles L, Yamamoto JH, Brissieux L, Sterenberg BT, Udachin KA, Carty AJ.

Inorg Chem. 2001 Dec 17;40(26):6731-6.

PMID:
11735485
20.

Lack of evidence for superantigen activity of Toxoplasma gondii towards human T cells.

Vallochi AL, Yamamoto JH, Schlesinger D, Machado MA, Silveira C, Martins MC, Belfort R Jr, Kalil J, Rizzo LV.

Braz J Med Biol Res. 2001 Aug;34(8):1023-31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk